Global Newcastle Disease Vaccine Market Size, Manufacturers, Opportunities and Forecast to 2030
Summary
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.
According to APO Research, The global Newcastle Disease Vaccine market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Newcastle Disease Vaccine include Merial, CEVA, QYH Biotech, Ringpu Biology, Yebio, Harbin Veterinary Research Institute, Merck Animal Health, DHN and Zoetis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Newcastle Disease Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newcastle Disease Vaccine.
The Newcastle Disease Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Newcastle Disease Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Newcastle Disease Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Newcastle Disease Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Newcastle Disease Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Newcastle Disease Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Newcastle Disease Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.
According to APO Research, The global Newcastle Disease Vaccine market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Newcastle Disease Vaccine include Merial, CEVA, QYH Biotech, Ringpu Biology, Yebio, Harbin Veterinary Research Institute, Merck Animal Health, DHN and Zoetis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Newcastle Disease Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newcastle Disease Vaccine.
The Newcastle Disease Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Newcastle Disease Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Merial
- CEVA
- QYH Biotech
- Ringpu Biology
- Yebio
- Harbin Veterinary Research Institute
- Merck Animal Health
- DHN
- Zoetis
- ChengDu Tecbond
- Elanco (Lohmann)
- FATRO
- CAVAC
- Vaksindo
- Live Vaccines
- Killed Vaccines
- Chicken
- Duck & Goose
- Other
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Newcastle Disease Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Newcastle Disease Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Newcastle Disease Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Newcastle Disease Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Newcastle Disease Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Newcastle Disease Vaccine Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Newcastle Disease Vaccine Sales Estimates and Forecasts (2019-2030)
1.3 Newcastle Disease Vaccine Market by Type
1.3.1 Live Vaccines
1.3.2 Killed Vaccines
1.4 Global Newcastle Disease Vaccine Market Size by Type
1.4.1 Global Newcastle Disease Vaccine Market Size Overview by Type (2019-2030)
1.4.2 Global Newcastle Disease Vaccine Historic Market Size Review by Type (2019-2024)
1.4.3 Global Newcastle Disease Vaccine Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Newcastle Disease Vaccine Sales Breakdown by Type (2019-2024)
1.5.2 Europe Newcastle Disease Vaccine Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Newcastle Disease Vaccine Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Newcastle Disease Vaccine Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Newcastle Disease Vaccine Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Newcastle Disease Vaccine Industry Trends
2.2 Newcastle Disease Vaccine Industry Drivers
2.3 Newcastle Disease Vaccine Industry Opportunities and Challenges
2.4 Newcastle Disease Vaccine Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Newcastle Disease Vaccine Revenue (2019-2024)
3.2 Global Top Players by Newcastle Disease Vaccine Sales (2019-2024)
3.3 Global Top Players by Newcastle Disease Vaccine Price (2019-2024)
3.4 Global Newcastle Disease Vaccine Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Newcastle Disease Vaccine Key Company Manufacturing Sites & Headquarters
3.6 Global Newcastle Disease Vaccine Company, Product Type & Application
3.7 Global Newcastle Disease Vaccine Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Newcastle Disease Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Newcastle Disease Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Newcastle Disease Vaccine Tier 1, Tier 2, and Tier
4 NEWCASTLE DISEASE VACCINE REGIONAL STATUS AND OUTLOOK
4.1 Global Newcastle Disease Vaccine Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Newcastle Disease Vaccine Historic Market Size by Region
4.2.1 Global Newcastle Disease Vaccine Sales in Volume by Region (2019-2024)
4.2.2 Global Newcastle Disease Vaccine Sales in Value by Region (2019-2024)
4.2.3 Global Newcastle Disease Vaccine Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Newcastle Disease Vaccine Forecasted Market Size by Region
4.3.1 Global Newcastle Disease Vaccine Sales in Volume by Region (2025-2030)
4.3.2 Global Newcastle Disease Vaccine Sales in Value by Region (2025-2030)
4.3.3 Global Newcastle Disease Vaccine Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 NEWCASTLE DISEASE VACCINE BY APPLICATION
5.1 Newcastle Disease Vaccine Market by Application
5.1.1 Chicken
5.1.2 Duck & Goose
5.1.3 Other
5.2 Global Newcastle Disease Vaccine Market Size by Application
5.2.1 Global Newcastle Disease Vaccine Market Size Overview by Application (2019-2030)
5.2.2 Global Newcastle Disease Vaccine Historic Market Size Review by Application (2019-2024)
5.2.3 Global Newcastle Disease Vaccine Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Newcastle Disease Vaccine Sales Breakdown by Application (2019-2024)
5.3.2 Europe Newcastle Disease Vaccine Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Newcastle Disease Vaccine Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Newcastle Disease Vaccine Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Newcastle Disease Vaccine Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Merial
6.1.1 Merial Comapny Information
6.1.2 Merial Business Overview
6.1.3 Merial Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merial Newcastle Disease Vaccine Product Portfolio
6.1.5 Merial Recent Developments
6.2 CEVA
6.2.1 CEVA Comapny Information
6.2.2 CEVA Business Overview
6.2.3 CEVA Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CEVA Newcastle Disease Vaccine Product Portfolio
6.2.5 CEVA Recent Developments
6.3 QYH Biotech
6.3.1 QYH Biotech Comapny Information
6.3.2 QYH Biotech Business Overview
6.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 QYH Biotech Newcastle Disease Vaccine Product Portfolio
6.3.5 QYH Biotech Recent Developments
6.4 Ringpu Biology
6.4.1 Ringpu Biology Comapny Information
6.4.2 Ringpu Biology Business Overview
6.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ringpu Biology Newcastle Disease Vaccine Product Portfolio
6.4.5 Ringpu Biology Recent Developments
6.5 Yebio
6.5.1 Yebio Comapny Information
6.5.2 Yebio Business Overview
6.5.3 Yebio Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Yebio Newcastle Disease Vaccine Product Portfolio
6.5.5 Yebio Recent Developments
6.6 Harbin Veterinary Research Institute
6.6.1 Harbin Veterinary Research Institute Comapny Information
6.6.2 Harbin Veterinary Research Institute Business Overview
6.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
6.6.5 Harbin Veterinary Research Institute Recent Developments
6.7 Merck Animal Health
6.7.1 Merck Animal Health Comapny Information
6.7.2 Merck Animal Health Business Overview
6.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Merck Animal Health Newcastle Disease Vaccine Product Portfolio
6.7.5 Merck Animal Health Recent Developments
6.8 DHN
6.8.1 DHN Comapny Information
6.8.2 DHN Business Overview
6.8.3 DHN Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 DHN Newcastle Disease Vaccine Product Portfolio
6.8.5 DHN Recent Developments
6.9 Zoetis
6.9.1 Zoetis Comapny Information
6.9.2 Zoetis Business Overview
6.9.3 Zoetis Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Zoetis Newcastle Disease Vaccine Product Portfolio
6.9.5 Zoetis Recent Developments
6.10 ChengDu Tecbond
6.10.1 ChengDu Tecbond Comapny Information
6.10.2 ChengDu Tecbond Business Overview
6.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
6.10.5 ChengDu Tecbond Recent Developments
6.11 Elanco (Lohmann)
6.11.1 Elanco (Lohmann) Comapny Information
6.11.2 Elanco (Lohmann) Business Overview
6.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
6.11.5 Elanco (Lohmann) Recent Developments
6.12 FATRO
6.12.1 FATRO Comapny Information
6.12.2 FATRO Business Overview
6.12.3 FATRO Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 FATRO Newcastle Disease Vaccine Product Portfolio
6.12.5 FATRO Recent Developments
6.13 CAVAC
6.13.1 CAVAC Comapny Information
6.13.2 CAVAC Business Overview
6.13.3 CAVAC Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 CAVAC Newcastle Disease Vaccine Product Portfolio
6.13.5 CAVAC Recent Developments
6.14 Vaksindo
6.14.1 Vaksindo Comapny Information
6.14.2 Vaksindo Business Overview
6.14.3 Vaksindo Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Vaksindo Newcastle Disease Vaccine Product Portfolio
6.14.5 Vaksindo Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Newcastle Disease Vaccine Sales by Country
7.1.1 North America Newcastle Disease Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Newcastle Disease Vaccine Sales by Country (2019-2024)
7.1.3 North America Newcastle Disease Vaccine Sales Forecast by Country (2025-2030)
7.2 North America Newcastle Disease Vaccine Market Size by Country
7.2.1 North America Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Newcastle Disease Vaccine Market Size by Country (2019-2024)
7.2.3 North America Newcastle Disease Vaccine Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Newcastle Disease Vaccine Sales by Country
8.1.1 Europe Newcastle Disease Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Newcastle Disease Vaccine Sales by Country (2019-2024)
8.1.3 Europe Newcastle Disease Vaccine Sales Forecast by Country (2025-2030)
8.2 Europe Newcastle Disease Vaccine Market Size by Country
8.2.1 Europe Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Newcastle Disease Vaccine Market Size by Country (2019-2024)
8.2.3 Europe Newcastle Disease Vaccine Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Newcastle Disease Vaccine Sales by Country
9.1.1 Asia-Pacific Newcastle Disease Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Newcastle Disease Vaccine Sales by Country (2019-2024)
9.1.3 Asia-Pacific Newcastle Disease Vaccine Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Newcastle Disease Vaccine Market Size by Country
9.2.1 Asia-Pacific Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Newcastle Disease Vaccine Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Newcastle Disease Vaccine Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Newcastle Disease Vaccine Sales by Country
10.1.1 Latin America Newcastle Disease Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Newcastle Disease Vaccine Sales by Country (2019-2024)
10.1.3 Latin America Newcastle Disease Vaccine Sales Forecast by Country (2025-2030)
10.2 Latin America Newcastle Disease Vaccine Market Size by Country
10.2.1 Latin America Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Newcastle Disease Vaccine Market Size by Country (2019-2024)
10.2.3 Latin America Newcastle Disease Vaccine Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Newcastle Disease Vaccine Sales by Country
11.1.1 Middle East and Africa Newcastle Disease Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Newcastle Disease Vaccine Sales by Country (2019-2024)
11.1.3 Middle East and Africa Newcastle Disease Vaccine Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Newcastle Disease Vaccine Market Size by Country
11.2.1 Middle East and Africa Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Newcastle Disease Vaccine Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Newcastle Disease Vaccine Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Newcastle Disease Vaccine Value Chain Analysis
12.1.1 Newcastle Disease Vaccine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Newcastle Disease Vaccine Production Mode & Process
12.2 Newcastle Disease Vaccine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Newcastle Disease Vaccine Distributors
12.2.3 Newcastle Disease Vaccine Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Newcastle Disease Vaccine Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Newcastle Disease Vaccine Sales Estimates and Forecasts (2019-2030)
1.3 Newcastle Disease Vaccine Market by Type
1.3.1 Live Vaccines
1.3.2 Killed Vaccines
1.4 Global Newcastle Disease Vaccine Market Size by Type
1.4.1 Global Newcastle Disease Vaccine Market Size Overview by Type (2019-2030)
1.4.2 Global Newcastle Disease Vaccine Historic Market Size Review by Type (2019-2024)
1.4.3 Global Newcastle Disease Vaccine Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Newcastle Disease Vaccine Sales Breakdown by Type (2019-2024)
1.5.2 Europe Newcastle Disease Vaccine Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Newcastle Disease Vaccine Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Newcastle Disease Vaccine Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Newcastle Disease Vaccine Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Newcastle Disease Vaccine Industry Trends
2.2 Newcastle Disease Vaccine Industry Drivers
2.3 Newcastle Disease Vaccine Industry Opportunities and Challenges
2.4 Newcastle Disease Vaccine Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Newcastle Disease Vaccine Revenue (2019-2024)
3.2 Global Top Players by Newcastle Disease Vaccine Sales (2019-2024)
3.3 Global Top Players by Newcastle Disease Vaccine Price (2019-2024)
3.4 Global Newcastle Disease Vaccine Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Newcastle Disease Vaccine Key Company Manufacturing Sites & Headquarters
3.6 Global Newcastle Disease Vaccine Company, Product Type & Application
3.7 Global Newcastle Disease Vaccine Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Newcastle Disease Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Newcastle Disease Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Newcastle Disease Vaccine Tier 1, Tier 2, and Tier
4 NEWCASTLE DISEASE VACCINE REGIONAL STATUS AND OUTLOOK
4.1 Global Newcastle Disease Vaccine Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Newcastle Disease Vaccine Historic Market Size by Region
4.2.1 Global Newcastle Disease Vaccine Sales in Volume by Region (2019-2024)
4.2.2 Global Newcastle Disease Vaccine Sales in Value by Region (2019-2024)
4.2.3 Global Newcastle Disease Vaccine Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Newcastle Disease Vaccine Forecasted Market Size by Region
4.3.1 Global Newcastle Disease Vaccine Sales in Volume by Region (2025-2030)
4.3.2 Global Newcastle Disease Vaccine Sales in Value by Region (2025-2030)
4.3.3 Global Newcastle Disease Vaccine Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 NEWCASTLE DISEASE VACCINE BY APPLICATION
5.1 Newcastle Disease Vaccine Market by Application
5.1.1 Chicken
5.1.2 Duck & Goose
5.1.3 Other
5.2 Global Newcastle Disease Vaccine Market Size by Application
5.2.1 Global Newcastle Disease Vaccine Market Size Overview by Application (2019-2030)
5.2.2 Global Newcastle Disease Vaccine Historic Market Size Review by Application (2019-2024)
5.2.3 Global Newcastle Disease Vaccine Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Newcastle Disease Vaccine Sales Breakdown by Application (2019-2024)
5.3.2 Europe Newcastle Disease Vaccine Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Newcastle Disease Vaccine Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Newcastle Disease Vaccine Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Newcastle Disease Vaccine Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Merial
6.1.1 Merial Comapny Information
6.1.2 Merial Business Overview
6.1.3 Merial Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merial Newcastle Disease Vaccine Product Portfolio
6.1.5 Merial Recent Developments
6.2 CEVA
6.2.1 CEVA Comapny Information
6.2.2 CEVA Business Overview
6.2.3 CEVA Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CEVA Newcastle Disease Vaccine Product Portfolio
6.2.5 CEVA Recent Developments
6.3 QYH Biotech
6.3.1 QYH Biotech Comapny Information
6.3.2 QYH Biotech Business Overview
6.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 QYH Biotech Newcastle Disease Vaccine Product Portfolio
6.3.5 QYH Biotech Recent Developments
6.4 Ringpu Biology
6.4.1 Ringpu Biology Comapny Information
6.4.2 Ringpu Biology Business Overview
6.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ringpu Biology Newcastle Disease Vaccine Product Portfolio
6.4.5 Ringpu Biology Recent Developments
6.5 Yebio
6.5.1 Yebio Comapny Information
6.5.2 Yebio Business Overview
6.5.3 Yebio Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Yebio Newcastle Disease Vaccine Product Portfolio
6.5.5 Yebio Recent Developments
6.6 Harbin Veterinary Research Institute
6.6.1 Harbin Veterinary Research Institute Comapny Information
6.6.2 Harbin Veterinary Research Institute Business Overview
6.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
6.6.5 Harbin Veterinary Research Institute Recent Developments
6.7 Merck Animal Health
6.7.1 Merck Animal Health Comapny Information
6.7.2 Merck Animal Health Business Overview
6.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Merck Animal Health Newcastle Disease Vaccine Product Portfolio
6.7.5 Merck Animal Health Recent Developments
6.8 DHN
6.8.1 DHN Comapny Information
6.8.2 DHN Business Overview
6.8.3 DHN Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 DHN Newcastle Disease Vaccine Product Portfolio
6.8.5 DHN Recent Developments
6.9 Zoetis
6.9.1 Zoetis Comapny Information
6.9.2 Zoetis Business Overview
6.9.3 Zoetis Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Zoetis Newcastle Disease Vaccine Product Portfolio
6.9.5 Zoetis Recent Developments
6.10 ChengDu Tecbond
6.10.1 ChengDu Tecbond Comapny Information
6.10.2 ChengDu Tecbond Business Overview
6.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
6.10.5 ChengDu Tecbond Recent Developments
6.11 Elanco (Lohmann)
6.11.1 Elanco (Lohmann) Comapny Information
6.11.2 Elanco (Lohmann) Business Overview
6.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
6.11.5 Elanco (Lohmann) Recent Developments
6.12 FATRO
6.12.1 FATRO Comapny Information
6.12.2 FATRO Business Overview
6.12.3 FATRO Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 FATRO Newcastle Disease Vaccine Product Portfolio
6.12.5 FATRO Recent Developments
6.13 CAVAC
6.13.1 CAVAC Comapny Information
6.13.2 CAVAC Business Overview
6.13.3 CAVAC Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 CAVAC Newcastle Disease Vaccine Product Portfolio
6.13.5 CAVAC Recent Developments
6.14 Vaksindo
6.14.1 Vaksindo Comapny Information
6.14.2 Vaksindo Business Overview
6.14.3 Vaksindo Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Vaksindo Newcastle Disease Vaccine Product Portfolio
6.14.5 Vaksindo Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Newcastle Disease Vaccine Sales by Country
7.1.1 North America Newcastle Disease Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Newcastle Disease Vaccine Sales by Country (2019-2024)
7.1.3 North America Newcastle Disease Vaccine Sales Forecast by Country (2025-2030)
7.2 North America Newcastle Disease Vaccine Market Size by Country
7.2.1 North America Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Newcastle Disease Vaccine Market Size by Country (2019-2024)
7.2.3 North America Newcastle Disease Vaccine Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Newcastle Disease Vaccine Sales by Country
8.1.1 Europe Newcastle Disease Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Newcastle Disease Vaccine Sales by Country (2019-2024)
8.1.3 Europe Newcastle Disease Vaccine Sales Forecast by Country (2025-2030)
8.2 Europe Newcastle Disease Vaccine Market Size by Country
8.2.1 Europe Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Newcastle Disease Vaccine Market Size by Country (2019-2024)
8.2.3 Europe Newcastle Disease Vaccine Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Newcastle Disease Vaccine Sales by Country
9.1.1 Asia-Pacific Newcastle Disease Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Newcastle Disease Vaccine Sales by Country (2019-2024)
9.1.3 Asia-Pacific Newcastle Disease Vaccine Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Newcastle Disease Vaccine Market Size by Country
9.2.1 Asia-Pacific Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Newcastle Disease Vaccine Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Newcastle Disease Vaccine Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Newcastle Disease Vaccine Sales by Country
10.1.1 Latin America Newcastle Disease Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Newcastle Disease Vaccine Sales by Country (2019-2024)
10.1.3 Latin America Newcastle Disease Vaccine Sales Forecast by Country (2025-2030)
10.2 Latin America Newcastle Disease Vaccine Market Size by Country
10.2.1 Latin America Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Newcastle Disease Vaccine Market Size by Country (2019-2024)
10.2.3 Latin America Newcastle Disease Vaccine Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Newcastle Disease Vaccine Sales by Country
11.1.1 Middle East and Africa Newcastle Disease Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Newcastle Disease Vaccine Sales by Country (2019-2024)
11.1.3 Middle East and Africa Newcastle Disease Vaccine Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Newcastle Disease Vaccine Market Size by Country
11.2.1 Middle East and Africa Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Newcastle Disease Vaccine Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Newcastle Disease Vaccine Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Newcastle Disease Vaccine Value Chain Analysis
12.1.1 Newcastle Disease Vaccine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Newcastle Disease Vaccine Production Mode & Process
12.2 Newcastle Disease Vaccine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Newcastle Disease Vaccine Distributors
12.2.3 Newcastle Disease Vaccine Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
LIST OF TABLES
Table 1. Major Company of Live Vaccines
Table 2. Major Company of Killed Vaccines
Table 3. Global Newcastle Disease Vaccine Sales by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 4. Global Newcastle Disease Vaccine Sales by Type (2019-2024) & (M Doses)
Table 5. Global Newcastle Disease Vaccine Sales Market Share in Volume by Type (2019-2024)
Table 6. Global Newcastle Disease Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 7. Global Newcastle Disease Vaccine Sales Market Share in Value by Type (2019-2024)
Table 8. Global Newcastle Disease Vaccine Price by Type (2019-2024) & (USD/K Doses)
Table 9. Global Newcastle Disease Vaccine Sales by Type (2025-2030) & (M Doses)
Table 10. Global Newcastle Disease Vaccine Sales Market Share in Volume by Type (2025-2030)
Table 11. Global Newcastle Disease Vaccine Sales by Type (2025-2030) & (US$ Million)
Table 12. Global Newcastle Disease Vaccine Sales Market Share in Value by Type (2025-2030)
Table 13. Global Newcastle Disease Vaccine Price by Type (2025-2030) & (USD/K Doses)
Table 14. North America Newcastle Disease Vaccine Sales by Type (2019-2024) & (M Doses)
Table 15. North America Newcastle Disease Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 16. Europe Newcastle Disease Vaccine Sales by Type (2019-2024) & (M Doses)
Table 17. Europe Newcastle Disease Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 18. Asia-Pacific Newcastle Disease Vaccine Sales by Type (2019-2024) & (M Doses)
Table 19. Asia-Pacific Newcastle Disease Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 20. Latin America Newcastle Disease Vaccine Sales by Type (2019-2024) & (M Doses)
Table 21. Latin America Newcastle Disease Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 22. Middle East and Africa Newcastle Disease Vaccine Sales by Type (2019-2024) & (M Doses)
Table 23. Middle East and Africa Newcastle Disease Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 24. Newcastle Disease Vaccine Industry Trends
Table 25. Newcastle Disease Vaccine Industry Drivers
Table 26. Newcastle Disease Vaccine Industry Opportunities and Challenges
Table 27. Newcastle Disease Vaccine Industry Restraints
Table 28. Global Newcastle Disease Vaccine Sales Revenue by Company (US$ Million) & (2019-2024)
Table 29. Global Newcastle Disease Vaccine Revenue Market Share by Company (2019-2024)
Table 30. Global Newcastle Disease Vaccine Sales by Company (2019-2024) & (M Doses)
Table 31. Global Newcastle Disease Vaccine Sales Share by Company (2019-2024)
Table 32. Global Newcastle Disease Vaccine Market Price by Company (2019-2024) & (USD/K Doses)
Table 33. Global Newcastle Disease Vaccine Industry Company Ranking, 2022 VS 2023 VS 2024
Table 34. Global Newcastle Disease Vaccine Key Company Manufacturing Sites & Headquarters
Table 35. Global Newcastle Disease Vaccine Company, Product Type & Application
Table 36. Global Newcastle Disease Vaccine Company Commercialization Time
Table 37. Global Company Market Concentration Ratio (CR5 and HHI)
Table 38. Global Newcastle Disease Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 39. Global Newcastle Disease Vaccine Market Size Comparison by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Global Newcastle Disease Vaccine Sales by Region (2019-2024) & (M Doses)
Table 41. Global Newcastle Disease Vaccine Sales Market Share in Volume by Region (2019-2024)
Table 42. Global Newcastle Disease Vaccine Sales by Region (2019-2024) & (US$ Million)
Table 43. Global Newcastle Disease Vaccine Sales Market Share in Value by Region (2019-2024)
Table 44. Global Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 45. Global Newcastle Disease Vaccine Sales by Region (2025-2030) & (M Doses)
Table 46. Global Newcastle Disease Vaccine Sales Market Share in Volume by Region (2025-2030)
Table 47. Global Newcastle Disease Vaccine Sales by Region (2025-2030) & (US$ Million)
Table 48. Global Newcastle Disease Vaccine Sales Market Share in Value by Region (2025-2030)
Table 49. Global Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2025-2030)
Table 50. Global Newcastle Disease Vaccine Sales by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 51. Global Newcastle Disease Vaccine Sales by Application (2019-2024) & (M Doses)
Table 52. Global Newcastle Disease Vaccine Sales Market Share in Volume by Application (2019-2024)
Table 53. Global Newcastle Disease Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 54. Global Newcastle Disease Vaccine Sales Market Share in Value by Application (2019-2024)
Table 55. Global Newcastle Disease Vaccine Price by Application (2019-2024) & (USD/K Doses)
Table 56. Global Newcastle Disease Vaccine Sales by Application (2025-2030) & (M Doses)
Table 57. Global Newcastle Disease Vaccine Sales Market Share in Volume by Application (2025-2030)
Table 58. Global Newcastle Disease Vaccine Sales by Application (2025-2030) & (US$ Million)
Table 59. Global Newcastle Disease Vaccine Sales Market Share in Value by Application (2025-2030)
Table 60. Global Newcastle Disease Vaccine Price by Application (2025-2030) & (USD/K Doses)
Table 61. North America Newcastle Disease Vaccine Sales by Application (2019-2024) & (M Doses)
Table 62. North America Newcastle Disease Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 63. Europe Newcastle Disease Vaccine Sales by Application (2019-2024) & (M Doses)
Table 64. Europe Newcastle Disease Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 65. Asia-Pacific Newcastle Disease Vaccine Sales by Application (2019-2024) & (M Doses)
Table 66. Asia-Pacific Newcastle Disease Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 67. Latin America Newcastle Disease Vaccine Sales by Application (2019-2024) & (M Doses)
Table 68. Latin America Newcastle Disease Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 69. Middle East and Africa Newcastle Disease Vaccine Sales by Application (2019-2024) & (M Doses)
Table 70. Middle East and Africa Newcastle Disease Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 71. Merial Company Information
Table 72. Merial Business Overview
Table 73. Merial Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 74. Merial Newcastle Disease Vaccine Product Portfolio
Table 75. Merial Recent Development
Table 76. CEVA Company Information
Table 77. CEVA Business Overview
Table 78. CEVA Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 79. CEVA Newcastle Disease Vaccine Product Portfolio
Table 80. CEVA Recent Development
Table 81. QYH Biotech Company Information
Table 82. QYH Biotech Business Overview
Table 83. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 84. QYH Biotech Newcastle Disease Vaccine Product Portfolio
Table 85. QYH Biotech Recent Development
Table 86. Ringpu Biology Company Information
Table 87. Ringpu Biology Business Overview
Table 88. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 89. Ringpu Biology Newcastle Disease Vaccine Product Portfolio
Table 90. Ringpu Biology Recent Development
Table 91. Yebio Company Information
Table 92. Yebio Business Overview
Table 93. Yebio Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 94. Yebio Newcastle Disease Vaccine Product Portfolio
Table 95. Yebio Recent Development
Table 96. Harbin Veterinary Research Institute Company Information
Table 97. Harbin Veterinary Research Institute Business Overview
Table 98. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 99. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
Table 100. Harbin Veterinary Research Institute Recent Development
Table 101. Merck Animal Health Company Information
Table 102. Merck Animal Health Business Overview
Table 103. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 104. Merck Animal Health Newcastle Disease Vaccine Product Portfolio
Table 105. Merck Animal Health Recent Development
Table 106. DHN Company Information
Table 107. DHN Business Overview
Table 108. DHN Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 109. DHN Newcastle Disease Vaccine Product Portfolio
Table 110. DHN Recent Development
Table 111. Zoetis Company Information
Table 112. Zoetis Business Overview
Table 113. Zoetis Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 114. Zoetis Newcastle Disease Vaccine Product Portfolio
Table 115. Zoetis Recent Development
Table 116. ChengDu Tecbond Company Information
Table 117. ChengDu Tecbond Business Overview
Table 118. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 119. ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
Table 120. ChengDu Tecbond Recent Development
Table 121. Elanco (Lohmann) Company Information
Table 122. Elanco (Lohmann) Business Overview
Table 123. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 124. Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
Table 125. Elanco (Lohmann) Recent Development
Table 126. FATRO Company Information
Table 127. FATRO Business Overview
Table 128. FATRO Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 129. FATRO Newcastle Disease Vaccine Product Portfolio
Table 130. FATRO Recent Development
Table 131. CAVAC Company Information
Table 132. CAVAC Business Overview
Table 133. CAVAC Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 134. CAVAC Newcastle Disease Vaccine Product Portfolio
Table 135. CAVAC Recent Development
Table 136. Vaksindo Company Information
Table 137. Vaksindo Business Overview
Table 138. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 139. Vaksindo Newcastle Disease Vaccine Product Portfolio
Table 140. Vaksindo Recent Development
Table 141. North America Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 142. North America Newcastle Disease Vaccine Sales by Country (2019-2024) & (M Doses)
Table 143. North America Newcastle Disease Vaccine Sales Market Share by Country (2019-2024)
Table 144. North America Newcastle Disease Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 145. North America Newcastle Disease Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 146. North America Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 147. North America Newcastle Disease Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 148. North America Newcastle Disease Vaccine Market Share by Country (2019-2024)
Table 149. North America Newcastle Disease Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 150. North America Newcastle Disease Vaccine Market Share Forecast by Country (2025-2030)
Table 151. Europe Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 152. Europe Newcastle Disease Vaccine Sales by Country (2019-2024) & (M Doses)
Table 153. Europe Newcastle Disease Vaccine Sales Market Share by Country (2019-2024)
Table 154. Europe Newcastle Disease Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 155. Europe Newcastle Disease Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 156. Europe Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 157. Europe Newcastle Disease Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 158. Europe Newcastle Disease Vaccine Market Share by Country (2019-2024)
Table 159. Europe Newcastle Disease Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 160. Europe Newcastle Disease Vaccine Market Share Forecast by Country (2025-2030)
Table 161. Asia-Pacific Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 162. Asia-Pacific Newcastle Disease Vaccine Sales by Country (2019-2024) & (M Doses)
Table 163. Asia-Pacific Newcastle Disease Vaccine Sales Market Share by Country (2019-2024)
Table 164. Asia-Pacific Newcastle Disease Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 165. Asia-Pacific Newcastle Disease Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 166. Asia-Pacific Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 167. Asia-Pacific Newcastle Disease Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 168. Asia-Pacific Newcastle Disease Vaccine Market Share by Country (2019-2024)
Table 169. Asia-Pacific Newcastle Disease Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 170. Asia-Pacific Newcastle Disease Vaccine Market Share Forecast by Country (2025-2030)
Table 171. Latin America Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 172. Latin America Newcastle Disease Vaccine Sales by Country (2019-2024) & (M Doses)
Table 173. Latin America Newcastle Disease Vaccine Sales Market Share by Country (2019-2024)
Table 174. Latin America Newcastle Disease Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 175. Latin America Newcastle Disease Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 176. Latin America Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 177. Latin America Newcastle Disease Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 178. Latin America Newcastle Disease Vaccine Market Share by Country (2019-2024)
Table 179. Latin America Newcastle Disease Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 180. Latin America Newcastle Disease Vaccine Market Share Forecast by Country (2025-2030)
Table 181. Middle East and Africa Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 182. Middle East and Africa Newcastle Disease Vaccine Sales by Country (2019-2024) & (M Doses)
Table 183. Middle East and Africa Newcastle Disease Vaccine Sales Market Share by Country (2019-2024)
Table 184. Middle East and Africa Newcastle Disease Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 185. Middle East and Africa Newcastle Disease Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 186. Middle East and Africa Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 187. Middle East and Africa Newcastle Disease Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 188. Middle East and Africa Newcastle Disease Vaccine Market Share by Country (2019-2024)
Table 189. Middle East and Africa Newcastle Disease Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 190. Middle East and Africa Newcastle Disease Vaccine Market Share Forecast by Country (2025-2030)
Table 191. Key Raw Materials
Table 192. Raw Materials Key Suppliers
Table 193. Newcastle Disease Vaccine Distributors List
Table 194. Newcastle Disease Vaccine Customers List
Table 195. Research Programs/Design for This Report
Table 196. Authors List of This Report
Table 197. Secondary Sources
Table 198. Primary Sources
Table 1. Major Company of Live Vaccines
Table 2. Major Company of Killed Vaccines
Table 3. Global Newcastle Disease Vaccine Sales by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 4. Global Newcastle Disease Vaccine Sales by Type (2019-2024) & (M Doses)
Table 5. Global Newcastle Disease Vaccine Sales Market Share in Volume by Type (2019-2024)
Table 6. Global Newcastle Disease Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 7. Global Newcastle Disease Vaccine Sales Market Share in Value by Type (2019-2024)
Table 8. Global Newcastle Disease Vaccine Price by Type (2019-2024) & (USD/K Doses)
Table 9. Global Newcastle Disease Vaccine Sales by Type (2025-2030) & (M Doses)
Table 10. Global Newcastle Disease Vaccine Sales Market Share in Volume by Type (2025-2030)
Table 11. Global Newcastle Disease Vaccine Sales by Type (2025-2030) & (US$ Million)
Table 12. Global Newcastle Disease Vaccine Sales Market Share in Value by Type (2025-2030)
Table 13. Global Newcastle Disease Vaccine Price by Type (2025-2030) & (USD/K Doses)
Table 14. North America Newcastle Disease Vaccine Sales by Type (2019-2024) & (M Doses)
Table 15. North America Newcastle Disease Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 16. Europe Newcastle Disease Vaccine Sales by Type (2019-2024) & (M Doses)
Table 17. Europe Newcastle Disease Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 18. Asia-Pacific Newcastle Disease Vaccine Sales by Type (2019-2024) & (M Doses)
Table 19. Asia-Pacific Newcastle Disease Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 20. Latin America Newcastle Disease Vaccine Sales by Type (2019-2024) & (M Doses)
Table 21. Latin America Newcastle Disease Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 22. Middle East and Africa Newcastle Disease Vaccine Sales by Type (2019-2024) & (M Doses)
Table 23. Middle East and Africa Newcastle Disease Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 24. Newcastle Disease Vaccine Industry Trends
Table 25. Newcastle Disease Vaccine Industry Drivers
Table 26. Newcastle Disease Vaccine Industry Opportunities and Challenges
Table 27. Newcastle Disease Vaccine Industry Restraints
Table 28. Global Newcastle Disease Vaccine Sales Revenue by Company (US$ Million) & (2019-2024)
Table 29. Global Newcastle Disease Vaccine Revenue Market Share by Company (2019-2024)
Table 30. Global Newcastle Disease Vaccine Sales by Company (2019-2024) & (M Doses)
Table 31. Global Newcastle Disease Vaccine Sales Share by Company (2019-2024)
Table 32. Global Newcastle Disease Vaccine Market Price by Company (2019-2024) & (USD/K Doses)
Table 33. Global Newcastle Disease Vaccine Industry Company Ranking, 2022 VS 2023 VS 2024
Table 34. Global Newcastle Disease Vaccine Key Company Manufacturing Sites & Headquarters
Table 35. Global Newcastle Disease Vaccine Company, Product Type & Application
Table 36. Global Newcastle Disease Vaccine Company Commercialization Time
Table 37. Global Company Market Concentration Ratio (CR5 and HHI)
Table 38. Global Newcastle Disease Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 39. Global Newcastle Disease Vaccine Market Size Comparison by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Global Newcastle Disease Vaccine Sales by Region (2019-2024) & (M Doses)
Table 41. Global Newcastle Disease Vaccine Sales Market Share in Volume by Region (2019-2024)
Table 42. Global Newcastle Disease Vaccine Sales by Region (2019-2024) & (US$ Million)
Table 43. Global Newcastle Disease Vaccine Sales Market Share in Value by Region (2019-2024)
Table 44. Global Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 45. Global Newcastle Disease Vaccine Sales by Region (2025-2030) & (M Doses)
Table 46. Global Newcastle Disease Vaccine Sales Market Share in Volume by Region (2025-2030)
Table 47. Global Newcastle Disease Vaccine Sales by Region (2025-2030) & (US$ Million)
Table 48. Global Newcastle Disease Vaccine Sales Market Share in Value by Region (2025-2030)
Table 49. Global Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2025-2030)
Table 50. Global Newcastle Disease Vaccine Sales by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 51. Global Newcastle Disease Vaccine Sales by Application (2019-2024) & (M Doses)
Table 52. Global Newcastle Disease Vaccine Sales Market Share in Volume by Application (2019-2024)
Table 53. Global Newcastle Disease Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 54. Global Newcastle Disease Vaccine Sales Market Share in Value by Application (2019-2024)
Table 55. Global Newcastle Disease Vaccine Price by Application (2019-2024) & (USD/K Doses)
Table 56. Global Newcastle Disease Vaccine Sales by Application (2025-2030) & (M Doses)
Table 57. Global Newcastle Disease Vaccine Sales Market Share in Volume by Application (2025-2030)
Table 58. Global Newcastle Disease Vaccine Sales by Application (2025-2030) & (US$ Million)
Table 59. Global Newcastle Disease Vaccine Sales Market Share in Value by Application (2025-2030)
Table 60. Global Newcastle Disease Vaccine Price by Application (2025-2030) & (USD/K Doses)
Table 61. North America Newcastle Disease Vaccine Sales by Application (2019-2024) & (M Doses)
Table 62. North America Newcastle Disease Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 63. Europe Newcastle Disease Vaccine Sales by Application (2019-2024) & (M Doses)
Table 64. Europe Newcastle Disease Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 65. Asia-Pacific Newcastle Disease Vaccine Sales by Application (2019-2024) & (M Doses)
Table 66. Asia-Pacific Newcastle Disease Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 67. Latin America Newcastle Disease Vaccine Sales by Application (2019-2024) & (M Doses)
Table 68. Latin America Newcastle Disease Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 69. Middle East and Africa Newcastle Disease Vaccine Sales by Application (2019-2024) & (M Doses)
Table 70. Middle East and Africa Newcastle Disease Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 71. Merial Company Information
Table 72. Merial Business Overview
Table 73. Merial Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 74. Merial Newcastle Disease Vaccine Product Portfolio
Table 75. Merial Recent Development
Table 76. CEVA Company Information
Table 77. CEVA Business Overview
Table 78. CEVA Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 79. CEVA Newcastle Disease Vaccine Product Portfolio
Table 80. CEVA Recent Development
Table 81. QYH Biotech Company Information
Table 82. QYH Biotech Business Overview
Table 83. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 84. QYH Biotech Newcastle Disease Vaccine Product Portfolio
Table 85. QYH Biotech Recent Development
Table 86. Ringpu Biology Company Information
Table 87. Ringpu Biology Business Overview
Table 88. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 89. Ringpu Biology Newcastle Disease Vaccine Product Portfolio
Table 90. Ringpu Biology Recent Development
Table 91. Yebio Company Information
Table 92. Yebio Business Overview
Table 93. Yebio Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 94. Yebio Newcastle Disease Vaccine Product Portfolio
Table 95. Yebio Recent Development
Table 96. Harbin Veterinary Research Institute Company Information
Table 97. Harbin Veterinary Research Institute Business Overview
Table 98. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 99. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
Table 100. Harbin Veterinary Research Institute Recent Development
Table 101. Merck Animal Health Company Information
Table 102. Merck Animal Health Business Overview
Table 103. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 104. Merck Animal Health Newcastle Disease Vaccine Product Portfolio
Table 105. Merck Animal Health Recent Development
Table 106. DHN Company Information
Table 107. DHN Business Overview
Table 108. DHN Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 109. DHN Newcastle Disease Vaccine Product Portfolio
Table 110. DHN Recent Development
Table 111. Zoetis Company Information
Table 112. Zoetis Business Overview
Table 113. Zoetis Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 114. Zoetis Newcastle Disease Vaccine Product Portfolio
Table 115. Zoetis Recent Development
Table 116. ChengDu Tecbond Company Information
Table 117. ChengDu Tecbond Business Overview
Table 118. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 119. ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
Table 120. ChengDu Tecbond Recent Development
Table 121. Elanco (Lohmann) Company Information
Table 122. Elanco (Lohmann) Business Overview
Table 123. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 124. Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
Table 125. Elanco (Lohmann) Recent Development
Table 126. FATRO Company Information
Table 127. FATRO Business Overview
Table 128. FATRO Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 129. FATRO Newcastle Disease Vaccine Product Portfolio
Table 130. FATRO Recent Development
Table 131. CAVAC Company Information
Table 132. CAVAC Business Overview
Table 133. CAVAC Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 134. CAVAC Newcastle Disease Vaccine Product Portfolio
Table 135. CAVAC Recent Development
Table 136. Vaksindo Company Information
Table 137. Vaksindo Business Overview
Table 138. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 139. Vaksindo Newcastle Disease Vaccine Product Portfolio
Table 140. Vaksindo Recent Development
Table 141. North America Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 142. North America Newcastle Disease Vaccine Sales by Country (2019-2024) & (M Doses)
Table 143. North America Newcastle Disease Vaccine Sales Market Share by Country (2019-2024)
Table 144. North America Newcastle Disease Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 145. North America Newcastle Disease Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 146. North America Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 147. North America Newcastle Disease Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 148. North America Newcastle Disease Vaccine Market Share by Country (2019-2024)
Table 149. North America Newcastle Disease Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 150. North America Newcastle Disease Vaccine Market Share Forecast by Country (2025-2030)
Table 151. Europe Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 152. Europe Newcastle Disease Vaccine Sales by Country (2019-2024) & (M Doses)
Table 153. Europe Newcastle Disease Vaccine Sales Market Share by Country (2019-2024)
Table 154. Europe Newcastle Disease Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 155. Europe Newcastle Disease Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 156. Europe Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 157. Europe Newcastle Disease Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 158. Europe Newcastle Disease Vaccine Market Share by Country (2019-2024)
Table 159. Europe Newcastle Disease Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 160. Europe Newcastle Disease Vaccine Market Share Forecast by Country (2025-2030)
Table 161. Asia-Pacific Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 162. Asia-Pacific Newcastle Disease Vaccine Sales by Country (2019-2024) & (M Doses)
Table 163. Asia-Pacific Newcastle Disease Vaccine Sales Market Share by Country (2019-2024)
Table 164. Asia-Pacific Newcastle Disease Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 165. Asia-Pacific Newcastle Disease Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 166. Asia-Pacific Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 167. Asia-Pacific Newcastle Disease Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 168. Asia-Pacific Newcastle Disease Vaccine Market Share by Country (2019-2024)
Table 169. Asia-Pacific Newcastle Disease Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 170. Asia-Pacific Newcastle Disease Vaccine Market Share Forecast by Country (2025-2030)
Table 171. Latin America Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 172. Latin America Newcastle Disease Vaccine Sales by Country (2019-2024) & (M Doses)
Table 173. Latin America Newcastle Disease Vaccine Sales Market Share by Country (2019-2024)
Table 174. Latin America Newcastle Disease Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 175. Latin America Newcastle Disease Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 176. Latin America Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 177. Latin America Newcastle Disease Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 178. Latin America Newcastle Disease Vaccine Market Share by Country (2019-2024)
Table 179. Latin America Newcastle Disease Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 180. Latin America Newcastle Disease Vaccine Market Share Forecast by Country (2025-2030)
Table 181. Middle East and Africa Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 182. Middle East and Africa Newcastle Disease Vaccine Sales by Country (2019-2024) & (M Doses)
Table 183. Middle East and Africa Newcastle Disease Vaccine Sales Market Share by Country (2019-2024)
Table 184. Middle East and Africa Newcastle Disease Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 185. Middle East and Africa Newcastle Disease Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 186. Middle East and Africa Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 187. Middle East and Africa Newcastle Disease Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 188. Middle East and Africa Newcastle Disease Vaccine Market Share by Country (2019-2024)
Table 189. Middle East and Africa Newcastle Disease Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 190. Middle East and Africa Newcastle Disease Vaccine Market Share Forecast by Country (2025-2030)
Table 191. Key Raw Materials
Table 192. Raw Materials Key Suppliers
Table 193. Newcastle Disease Vaccine Distributors List
Table 194. Newcastle Disease Vaccine Customers List
Table 195. Research Programs/Design for This Report
Table 196. Authors List of This Report
Table 197. Secondary Sources
Table 198. Primary Sources
LIST OF FIGURES
Figure 1. Newcastle Disease Vaccine Product Picture
Figure 2. Global Newcastle Disease Vaccine Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Newcastle Disease Vaccine Market Size (2019-2030) & (US$ Million)
Figure 4. Global Newcastle Disease Vaccine Sales (2019-2030) & (M Doses)
Figure 5. Product Picture of Live Vaccines
Figure 6. Global Live Vaccines Sales YoY Growth (2019-2030) & (M Doses)
Figure 7. Product Picture of Killed Vaccines
Figure 8. Global Killed Vaccines Sales YoY Growth (2019-2030) & (M Doses)
Figure 9. Global Newcastle Disease Vaccine Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 10. Global Newcastle Disease Vaccine Market Share by Type 2023 VS 2030
Figure 11. North America Newcastle Disease Vaccine Sales Market Share in Volume by Type in 2023
Figure 12. North America Newcastle Disease Vaccine Sales Market Share in Value by Type in 2023
Figure 13. Europe Newcastle Disease Vaccine Sales Market Share in Volume by Type in 2023
Figure 14. Europe Newcastle Disease Vaccine Sales Market Share in Value by Type in 2023
Figure 15. Asia-Pacific Newcastle Disease Vaccine Sales Market Share in Volume by Type in 2023
Figure 16. Asia-Pacific Newcastle Disease Vaccine Sales Market Share in Value by Type in 2023
Figure 17. Latin America Newcastle Disease Vaccine Sales Market Share in Volume by Type in 2023
Figure 18. Latin America Newcastle Disease Vaccine Sales Market Share in Value by Type in 2023
Figure 19. Middle East and Africa Newcastle Disease Vaccine Sales Market Share in Volume by Type in 2023
Figure 20. Middle East and Africa Newcastle Disease Vaccine Sales Market Share in Value by Type in 2023
Figure 21. Global Top 5 and 10 Newcastle Disease Vaccine Players Market Share by Revenue in 2023
Figure 22. Company Typ
Figure 1. Newcastle Disease Vaccine Product Picture
Figure 2. Global Newcastle Disease Vaccine Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Newcastle Disease Vaccine Market Size (2019-2030) & (US$ Million)
Figure 4. Global Newcastle Disease Vaccine Sales (2019-2030) & (M Doses)
Figure 5. Product Picture of Live Vaccines
Figure 6. Global Live Vaccines Sales YoY Growth (2019-2030) & (M Doses)
Figure 7. Product Picture of Killed Vaccines
Figure 8. Global Killed Vaccines Sales YoY Growth (2019-2030) & (M Doses)
Figure 9. Global Newcastle Disease Vaccine Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 10. Global Newcastle Disease Vaccine Market Share by Type 2023 VS 2030
Figure 11. North America Newcastle Disease Vaccine Sales Market Share in Volume by Type in 2023
Figure 12. North America Newcastle Disease Vaccine Sales Market Share in Value by Type in 2023
Figure 13. Europe Newcastle Disease Vaccine Sales Market Share in Volume by Type in 2023
Figure 14. Europe Newcastle Disease Vaccine Sales Market Share in Value by Type in 2023
Figure 15. Asia-Pacific Newcastle Disease Vaccine Sales Market Share in Volume by Type in 2023
Figure 16. Asia-Pacific Newcastle Disease Vaccine Sales Market Share in Value by Type in 2023
Figure 17. Latin America Newcastle Disease Vaccine Sales Market Share in Volume by Type in 2023
Figure 18. Latin America Newcastle Disease Vaccine Sales Market Share in Value by Type in 2023
Figure 19. Middle East and Africa Newcastle Disease Vaccine Sales Market Share in Volume by Type in 2023
Figure 20. Middle East and Africa Newcastle Disease Vaccine Sales Market Share in Value by Type in 2023
Figure 21. Global Top 5 and 10 Newcastle Disease Vaccine Players Market Share by Revenue in 2023
Figure 22. Company Typ
